Facebook
X
LinkedIn
ForwardeContouring for Oligometastatic Prostate Cancer Webinar
Local therapies are increasingly being utilized in the treatment of oligometastatic prostate cancer. This webinar will aim to review aspects of management and treatment of oligometastatic prostate cancer including discussions of contouring and plan evaluation.
Live Webinar: January 26. 2026, at 12 p.m. Eastern time
During the live event, faculty will present a didactic background lecture followed by case/contour review and Q&A. Participants can access the presentation recording along with the practice cases until the activity expiration date to continue to practice contours and improve their score.
This activity is available from January 26, 2026, through January 27, 2027.
Target Audience
This course is designed to meet the interest of radiation oncologists, medical oncologists, surgeons and radiation oncology residents.
Learning Objectives
Upon completion of this live activity, participants should be able to:
- Understand management of oligometastatic prostate cancer.
- Understand contouring aspects of oligometastatic prostate cancer.
Planners
Salma Jabbour, MD, FASTRO, is employed by Rutgers Cancer Institute and receives funding from Merck & Co., Inc, Beigene, Radialogica, IMX Medical, Dechert LLC, AstraZeneca. She serves in a leadership position with the International Journal of Radiation Oncology, Biology, Physics (IJROBP)
Manisha Palta, MD, is employed by Duke University and receives research funding from Merck and Varian Medical Systems. She is a consultant for Varian Medical Systems, Voxelmetric and Syntaxtx and serves on an advisory board for Varian Medical Systems.
Faculty
Matthew Deek, MD, is employed Rutgers University.
The person(s) above served as the developer(s) of this activity.
All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
Price
Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
- Nonmember: $179
- Member: $119
- Member-in-Training: $59
If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until January 25, 2027, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.